445 reports of this reaction
1.8% of all HUMAN INSULIN reports
#9 most reported adverse reaction
HYPOGLYCAEMIA is the #9 most commonly reported adverse reaction for HUMAN INSULIN, manufactured by Novo Nordisk. There are 445 FDA adverse event reports linking HUMAN INSULIN to HYPOGLYCAEMIA. This represents approximately 1.8% of all 24,125 adverse event reports for this drug.
Patients taking HUMAN INSULIN who experience hypoglycaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOGLYCAEMIA is a less commonly reported adverse event for HUMAN INSULIN, but still significant enough to appear in the safety profile.
In addition to hypoglycaemia, the following adverse reactions have been reported for HUMAN INSULIN:
The following drugs have also been linked to hypoglycaemia in FDA adverse event reports:
HYPOGLYCAEMIA has been reported as an adverse event in 445 FDA reports for HUMAN INSULIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOGLYCAEMIA accounts for approximately 1.8% of all adverse event reports for HUMAN INSULIN, making it a notable side effect.
If you experience hypoglycaemia while taking HUMAN INSULIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.